Question 1

How will the 18F-DOPA-PET imaging help in monitoring my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study clinical trial (NCT02038348). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study clinical trial (NCT02038348). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this imaging compare to the standard imaging methods I am currently using?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study clinical trial (NCT02038348). Contact the study team or your healthcare provider for specific answers.

Question 4

What will happen if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study clinical trial (NCT02038348). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to come in for imaging and other assessments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study clinical trial (NCT02038348). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens after the study is completed?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study clinical trial (NCT02038348). Contact the study team or your healthcare provider for specific answers.

What this study is about